SEARCH
You are in browse mode. You must login to use MEMORY

   Log in to start


From course:

DRUG DISCOVERY DEVELOPMENT (DDD)

» Start this Course
(Practice similar questions for free)
Question:

Additional blinding of the biostatistician and Data Safety and Monitory Board → comparative safety and efficacy

Author: LEIGHTON DWIGHT OBILLOS



Answer:

Triple blinding


0 / 5  (0 ratings)

1 answer(s) in total